India Bronchodilators Market Size & Outlook, 2022-2030

The bronchodilators market in India is expected to reach a projected revenue of US$ 955.2 million by 2030. A compound annual growth rate of 5.8% is expected of India bronchodilators market from 2023 to 2030.
Revenue, 2022 (US$M)
$606.6
Forecast, 2030 (US$M)
$955.2
CAGR, 2023 - 2030
5.8%
Report Coverage
India

India bronchodilators market highlights

  • The India bronchodilators market generated a revenue of USD 606.6 million in 2022 and is expected to reach USD 955.2 million by 2030.
  • The India market is expected to grow at a CAGR of 5.8% from 2023 to 2030.
  • In terms of segment, beta-adrenergic bronchodilators was the largest revenue generating drug class in 2022.
  • Beta-Adrenergic Bronchodilators is the most lucrative drug class segment registering the fastest growth during the forecast period.


Bronchodilators market data book summary

Market revenue in 2022USD 606.6 million
Market revenue in 2030USD 955.2 million
Growth rate5.8% (CAGR from 2022 to 2030)
Largest segmentBeta-adrenergic bronchodilators
Fastest growing segmentBeta-Adrenergic Bronchodilators
Historical data2018 - 2021
Base year2022
Forecast period2023 - 2030
Quantitative unitsRevenue in USD million
Market segmentationBeta-Adrenergic Bronchodilators, Anticholinergic Bronchodilators, Xanthine Derivatives
Key market players worldwideGSK PLC, AstraZeneca PLC, Teva Pharmaceutical Industries Ltd, Cipla Ltd DR, Mylan, Merck KGaA, Merck & Co Inc, Novartis AG ADR, Boehringer Ingelheim, Sun Pharmaceutical Industries, Glenmark Pharmaceuticals


Other key industry trends

  • In terms of revenue, India accounted for 2.7% of the global bronchodilators market in 2022.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Asia Pacific, China bronchodilators market is projected to lead the regional market in terms of revenue in 2030.
  • China is the fastest growing regional market in Asia Pacific and is projected to reach USD 1,743.3 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Bronchodilators Market Companies

Name Profile # Employees HQ Website

India bronchodilators market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to bronchodilators market will help companies and investors design strategic landscapes.


Beta-adrenergic bronchodilators was the largest segment with a revenue share of 41.15% in 2022. Horizon Databook has segmented the India bronchodilators market based on beta-adrenergic bronchodilators, anticholinergic bronchodilators, xanthine derivatives covering the revenue growth of each sub-segment from 2018 to 2030.


Reasons to subscribe to India bronchodilators market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of India bronchodilators market databook

  • Our clientele includes a mix of bronchodilators market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the India bronchodilators market, including forecasts for subscribers. This country databook contains high-level insights into India bronchodilators market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

India bronchodilators market report size, by drug class, 2018-2030 (US$M)

India Bronchodilators Market Share, 2022 & 2030 (US$M)

India bronchodilators market report size, by drug class, 2018-2030 (US$M)

Related regional statistics

No records

No related regions found.

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more